Compare BridgeBio Pharma Inc (BBIO) vs iShares MSCI South Africa ETF (EZA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs iShares MSCI South Africa ETF — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while iShares MSCI South Africa ETF trades at $63.48. The key difference: BridgeBio Pharma Inc is trading nearer its 52-week high, iShares MSCI South Africa ETF nearer its low. Which is the better fit depends on your goals.
| BBIO | EZA | |
|---|---|---|
Market Cap | $16.27B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $90.17 | $81.60 |
52-Week Low | $44.81 | $52.86 |
Enterprise Value | $17.82B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About iShares MSCI South Africa ETF
EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →
